FDA Inspection 1295674 — Jason A. Ohayon, MD
The FDA completed an inspection of Jason A. Ohayon, MD on November 12, 2025 in Hamilton. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- November 12, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Hamilton (Canada)
Additional Details
Clinical BA/BE